Fernando Lecanda Selected Research

Fernando Lecanda Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 08/2004
20	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2008
18	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 01/2008
11	Lung Neoplasms (Lung Cancer) 01/2022 - 10/2007
7	Carcinogenesis 01/2020 - 08/2004
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2014
3	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 01/2019
3	Inflammation (Inflammations) 12/2014 - 08/2004
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2017
2	Carcinoma (Carcinomatosis) 04/2017 - 08/2004
2	Adenocarcinoma of Lung 12/2014 - 07/2012
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2021
1	Osteoradionecrosis 01/2021
1	Cholangiocarcinoma 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021
1	Necrosis 01/2021
1	Starvation 01/2020
1	Circulating Neoplastic Cells 11/2018
1	Urinary Bladder Neoplasms (Bladder Cancer) 12/2015
1	Disease Progression 10/2015
1	Lymphoma (Lymphomas) 10/2012
1	Infections 10/2012

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2012
7	Proteins (Proteins, Gene)FDA Link 10/2019 - 04/2008
5	Small Interfering RNA (siRNA)IBA 10/2020 - 06/2012
5	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2013
4	LigandsIBA 01/2020 - 08/2009
3	Zoledronic Acid (Zometa)FDA Link 04/2017 - 01/2011
3	Silicon Dioxide (Silica)FDA LinkGeneric 12/2014 - 08/2004
2	Complement C5a (Complement 5a)IBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 11/2020 - 07/2013
2	CollagenIBA 10/2020 - 02/2012
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2017
2	Cysteine-Rich Protein 61IBA 01/2019 - 07/2011
2	Cadherins (E-Cadherin)IBA 01/2019 - 08/2004
2	Endothelial Protein C ReceptorIBA 01/2017 - 07/2012
2	Proteoglycans (Proteoglycan)IBA 01/2017 - 06/2012
2	Oncogene Proteins (Oncogene Protein)IBA 01/2013 - 09/2007
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2012 - 01/2011
2	ErbB Receptors (EGF Receptor)IBA 10/2012 - 10/2007
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	HaptoglobinsIBA 01/2022
1	AminopropionitrileIBA 10/2020
1	Gemcitabine FDA Link 07/2020
1	edelfosineIBA 07/2020
1	nasIBA 07/2020
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2020
1	Insulin-Like PeptidesIBA 01/2020
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2020
1	src-Family KinasesIBA 10/2019
1	Dasatinib (BMS 354825)FDA Link 10/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Therapeutic UsesIBA 11/2018
1	Interleukin-33IBA 01/2018
1	LuciferasesIBA 04/2017
1	AntibodiesIBA 01/2017
1	OsteonectinIBA 01/2017
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2016
1	Matrix Gla ProteinIBA 01/2016
1	cyclo(Arg-Pro) (CI 4)IBA 12/2015
1	Pharmaceutical PreparationsIBA 10/2015
1	trans-sodium crocetinate (crocetin)IBA 09/2015
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 12/2014
1	CarcinogensIBA 12/2014
1	SmokeIBA 12/2014
1	Cisplatin (Platino)FDA LinkGeneric 10/2014
1	taxaneIBA 03/2014
1	Monomeric GTP-Binding ProteinsIBA 03/2014
1	CateninsIBA 01/2013
1	ProcollagenIBA 01/2013
1	UbiquitinIBA 10/2012
1	Proto-Oncogene Proteins c-cblIBA 10/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2012
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2012
1	Blocking AntibodiesIBA 07/2012
1	Protein CIBA 07/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2012
1	Methotrexate (Mexate)FDA LinkGeneric 06/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2012
1	Cytotoxins (Cytolysins)IBA 06/2012
1	CytokinesIBA 06/2012
1	Endothelin-1 (Endothelin 1)IBA 06/2012
1	Syndecan-2IBA 06/2012
1	Discoidin Domain ReceptorsIBA 02/2012
1	Collagen ReceptorsIBA 02/2012
1	RNA (Ribonucleic Acid)IBA 01/2012

Therapy/Procedure

6	Therapeutics 01/2021 - 01/2017
4	Brachytherapy 01/2021 - 09/2018
4	Drug Therapy (Chemotherapy) 10/2014 - 01/2012
3	Radiotherapy 01/2022 - 01/2018
3	Transplantation 10/2020 - 12/2014
2	Intramuscular Injections 07/2011 - 09/2007
1	Immunotherapy 01/2020
1	Adjuvant Chemotherapy 01/2019
1	Injections 11/2018